Drugs / bupivacaine 0.5% and oxubuprocaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05069350 | Sep 2021 → Aug 2022 | — | Research Institute of Ophthalmology, Egypt | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bupivacaine 0.5% and oxubuprocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05069350 ↗ |